Mimicry of Amyloid Oligomers
淀粉样蛋白寡聚物的模拟
基本信息
- 批准号:9205515
- 负责人:
- 金额:$ 29.14万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2020-01-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAmino AcidsAmyloidAmyloid beta-ProteinAmyloidosisBiologicalBiological ModelsC-terminalChemical ModelsDiseaseGoalsKnowledgeLeadMeasuresMolecularMutationNeurodegenerative DisordersParkinson DiseasePeptidesPharmaceutical PreparationsPhasePrion DiseasesPropertyProteinsResolutionRoentgen RaysStructureTailThermodynamicsabeta oligomeramyloid peptidebeta pleated sheetbiophysical analysisbiophysical propertiescrosslinkcytotoxicitydesignmimicrynovel therapeuticspolypeptideprevent
项目摘要
Project Summary/Abstract: Mimicry of Amyloid Oligomers
Amyloid oligomers now thought to be the damaging molecular species in Alzheimer's disease, Parkinson's
disease, and many other amyloid diseases. Understanding the structures of these oligomers is essential to
understanding their mechanism of action, and quite possibly to developing drugs to prevent or treat these
diseases. Studying the structures of the oligomers at high resolution is challenging, because the oligomers are
heterogeneous and dynamic, forming a variety of sizes and structures that can interconvert. The oligomers are
metastable, with fibrils being the more thermodynamically stable species. Only a few studies have provided
glimpses of amyloid oligomers at atomic resolution. Thus far, the there are no atomic-resolution structures of
oligomers of the beta-amyloid peptide, Abeta, the 40 or 42 amino acid polypeptide closely associated with
Alzheimer's disease.
This proposal aims to determine the structures of oligomers formed by Abeta by incorporating key
fragments of Abeta into macrocyclic beta-sheet peptides designed to mimic the key beta-hairpin building
blocks that are thought to make up Abeta oligomers. The PI has determined X-ray crystallographic structures
at atomic resolution of trimers formed macrocyclic beta-sheet peptides containing fragments from the central
and the C-terminal regions of Abeta. The trimers have a hitherto unprecedented structure consisting of a
triangular arrangement of beta-hairpins that pack together at the three vertices. The trimers further assemble to
form hexamers and dodecamers.
This proposal aims to build on the discovery of these trimers and higher-order oligomeric assemblies. The
broad overarching goal is to understand the relationship between the atomic-resolution structures of the
oligomers and their biological and biophysical properties. To achieve these goals, the PI will synthesize
macrocyclic beta-sheet peptides that incorporate different aspects of Abeta structure, determine the X-ray
crystallographic structures of the oligomers that these peptides form, measure their cytotoxicity, elucidate their
mechanisms of cytotoxcity, and correlate their cytotoxicity and their crystallographic structure by means of
biophysical studies of their solution-phase properties.
项目摘要/摘要:淀粉样蛋白低聚物的模仿
淀粉样蛋白低聚物现在被认为是阿尔茨海默氏病的破坏分子物种,帕金森氏症
疾病和许多其他淀粉样蛋白疾病。了解这些低聚物的结构对于
了解它们的作用机制,并且很可能开发药物以预防或治疗这些药物
疾病。在高分辨率上研究低分辨率的结构是具有挑战性的,因为低聚物是
异质和动态,形成可以互连的各种尺寸和结构。低聚物是
可稳态,纤维是热力学稳定的物种。只提供了少数研究
淀粉样蛋白低聚物在原子分辨率上的一瞥。到目前为止,没有原子分辨率结构
β-淀粉样蛋白肽的低聚物Abeta,40或42个氨基酸多肽与与
阿尔茨海默氏病。
该建议旨在通过合并钥匙来确定Abeta形成的低聚物的结构
Abeta的碎片成巨型β-β-β-型肽,旨在模仿关键的β发hairpin建筑
被认为构成Abeta低聚物的块。 PI已确定X射线晶体结构
在原子分辨率上,三聚体形成的大环β-β-
和Abeta的C末端区域。三聚体迄今为止的空前结构,由
β发pins的三角形布置在三个顶点包装在一起。三聚机进一步组装到
形成六聚体和企业。
该建议旨在建立在这些三聚体和高阶寡聚组件的基础上。这
广泛的总体目标是了解原子分辨率结构之间的关系
低聚物及其生物学和生物物理特性。为了实现这些目标,PI将合成
大环β-β-β-型肽,结合了Abeta结构的不同方面,确定X射线
这些肽形成的低聚物的晶体学结构,测量其细胞毒性,阐明它们
细胞毒素的机制,并通过其细胞毒性及其晶体学结构相关联
其溶液相特性的生物物理研究。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
JAMES S NOWICK其他文献
JAMES S NOWICK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('JAMES S NOWICK', 18)}}的其他基金
Synthesis and Evaluation of aza-Novo29 as an Antibiotic Candidate
候选抗生素 aza-Novo29 的合成与评价
- 批准号:
10527638 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
Synthesis and Evaluation of aza-Novo29 as an Antibiotic Candidate
候选抗生素 aza-Novo29 的合成与评价
- 批准号:
10624354 - 财政年份:2022
- 资助金额:
$ 29.14万 - 项目类别:
Structural and Biological Characterization of Diverse Oligomers Derived from Abeta
Abeta 衍生的多种低聚物的结构和生物学表征
- 批准号:
10214205 - 财政年份:2021
- 资助金额:
$ 29.14万 - 项目类别:
Synthesis and Studies of a New Family of Antibiotics
新抗生素家族的合成与研究
- 批准号:
9231356 - 财政年份:2016
- 资助金额:
$ 29.14万 - 项目类别:
Synthesis and Studies of a New Family of Antibiotics
新抗生素家族的合成与研究
- 批准号:
9014830 - 财政年份:2016
- 资助金额:
$ 29.14万 - 项目类别:
Chemical Models of Protein beta-Sheet Interactions
蛋白质 β-折叠相互作用的化学模型
- 批准号:
7847773 - 财政年份:2009
- 资助金额:
$ 29.14万 - 项目类别:
相似国自然基金
基于约氏副拟杆菌介导的“支链氨基酸-短链支链脂肪酸”转化研究牛膝多糖调控巨噬细胞促炎/抑炎功能防治糖尿病肾脏疾病的作用机制
- 批准号:82374105
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
应用非天然氨基酸系统修复肌肉干细胞及干性维持的调控机制
- 批准号:21672016
- 批准年份:2016
- 资助金额:30.0 万元
- 项目类别:面上项目
氨基酸变异与神经退化疾病关联性的融合分析模型
- 批准号:61602332
- 批准年份:2016
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
谷胱甘肽和巯基氨基酸总量时空同步检测荧光探针的开发与应用
- 批准号:21676113
- 批准年份:2016
- 资助金额:64.0 万元
- 项目类别:面上项目
手性氨基酸识别毛细管电色谱在重大疾病早期诊断中的应用研究
- 批准号:21675163
- 批准年份:2016
- 资助金额:65.0 万元
- 项目类别:面上项目
相似海外基金
Designing novel therapeutics for Alzheimer’s disease using structural studies of tau
利用 tau 蛋白结构研究设计治疗阿尔茨海默病的新疗法
- 批准号:
10678341 - 财政年份:2023
- 资助金额:
$ 29.14万 - 项目类别:
Stabilizing the tripartite synaptic complex following TBI
TBI 后稳定三方突触复合体
- 批准号:
10844877 - 财政年份:2023
- 资助金额:
$ 29.14万 - 项目类别:
Evaluation of a specific LXR/PPAR agonist for treatment of Alzheimer's disease
特定 LXR/PPAR 激动剂治疗阿尔茨海默病的评估
- 批准号:
10578068 - 财政年份:2023
- 资助金额:
$ 29.14万 - 项目类别:
Role of mitochondrial GDAP1 in Alzheimer's disease
线粒体 GDAP1 在阿尔茨海默病中的作用
- 批准号:
10739858 - 财政年份:2023
- 资助金额:
$ 29.14万 - 项目类别:
Dissecting connections between diet, the microbiome and Alzheimers disease
剖析饮食、微生物组和阿尔茨海默病之间的联系
- 批准号:
10740056 - 财政年份:2023
- 资助金额:
$ 29.14万 - 项目类别: